CLINICAL_TRIALS
trial_result
· 2017-02-01
Clinical Trial Update: Cellulose Powder Against Grass Pollen Allergic Rhinitis [Phase 2, Phase 3]
Summary
Update on Phase 2 and Phase 3 trials evaluating cellulose powder for grass pollen-induced allergic rhinitis, conducted by Nasaleze International Ltd, which have…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nasaleze International Ltd | Conditions: Allergic Rhinitis | Phase 2, Phase 3 | Status: COMPLETED